scholarly article | Q13442814 |
P356 | DOI | 10.1016/0360-3016(94)90291-7 |
P698 | PubMed publication ID | 8195035 |
P50 | author | Adrian Harris | Q37374768 |
Adam Patterson | Q38324051 | ||
Ian Stratford | Q56529169 | ||
P2093 | author name string | N Robertson | |
J Carmichael | |||
G E Adams | |||
M A Stephens | |||
S Houlbrook | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 369-372 | |
P577 | publication date | 1994-05-01 | |
P1433 | published in | International Journal of Radiation Oncology Biology Physics | Q2296252 |
P1476 | title | The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233) | |
P478 | volume | 29 |
Q41099312 | Adaptation of human tumor cells to tirapazamine under aerobic conditions: implications of increased antioxidant enzyme activity to mechanism of aerobic cytotoxicity |
Q41078518 | Enzymology of bioreductive drug activation |
Q42261948 | Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233). |
Q28383023 | Induction of DT-diaphorase by 1,2-dithiole-3-thione and increase of antitumour activity of bioreductive agents |
Q36292457 | Induction of DT-diaphorase by 1,2-dithiole-3-thiones in human tumour and normal cells and effect on anti-tumour activity of bioreductive agents |
Q35718471 | Induction of NQO1 in cancer cells |
Q39769351 | Maximizing bactericidal activity with combinations of bioreduced drugs |
Q43797318 | Metabolism of tirapazamine by multiple reductases in the nucleus |
Q40899249 | NADPH:cytochrome c (P450) reductase activates tirapazamine (SR4233) to restore hypoxic and oxic cytotoxicity in an aerobic resistant derivative of the A549 lung cancer cell line |
Q36431422 | Overexpression of human NADPH:cytochrome c (P450) reductase confers enhanced sensitivity to both tirapazamine (SR 4233) and RSU 1069 |
Q26752388 | Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of Actions |
Q28547408 | Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli |
Q26774750 | Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs |
Q34090988 | Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia |
Search more.